Danya Institute Inc.

Opioid Crisis: NIH Launches New Push to Fight Epidemic

From NBC News. To read the full article, click here.


by Maggie Fox

The National Institutes of Health announced a new push Wednesday to fight the opioid crisis, with fresh efforts to develop better drugs to fight addiction, to treat pain, and to stop overdoses.

The giant agency — the world’s biggest funder of medical research — is meeting with drugmakers to figure out the best and fastest ways to come up with a better solution to treating pain than the current addictive opioid class of drugs.

“Every day, more than 90 Americans die from opioid overdoses,” NIH director Dr. Francis Collins and Dr. Nora Volkow, head of the NIH’s National Institute for Drug Abuse, wrote in a special report for the New England Journal of Medicine.

Collins said the NIH will be meeting with “a dozen or more” drug companies over the coming weeks to develop better overdose drugs; better drugs to treat opioid addiction; and pain drugs that not only work better, but that are not addictive.

“Some may be reformulations of drugs that we already know can be used for treatment of overdoses,” Collins told reporters. “Some of them will be totally new ideas about pathways that have been recently discovered.”

One example: Narcan nasal spray, a quick-acting formulation of naloxone (Adapt Pharma Inc’s Narcan) that was approved by the Food and Drug Administration in 2015. The opioid antagonist blocks the effects of the opioid drugs, which slow breathing, sometimes fatally. NIH and the drug’s maker collaborated to develop it and get it approved.

“The NIH will now work with private partners to develop stronger, longer-acting formulations of antagonists, including naloxone, to counteract the very-high-potency synthetic opioids that are now claiming thousands of lives each year,” Collins and Volkow wrote.

“Industry is very interested and committed,” Collin added in the phone briefing.

Getting there may not be easy. “Reformulating opioids to deter abuse doesn’t improve their efficacy, and opioids haven’t been shown to relieve pain or improve functioning any better than nonopioid medications or nonpharmacologic treatments — which is the primary reason the CDC recommended those alternatives for managing chronic noncancer pain,” Dr. William Becker and Dr. David Fiellin, both of Yale University, wrote in a separate commentary in the New England Journal of Medicine.